---
figid: PMC7921671__41416_2020_1156_Fig5_HTML
figtitle: 'Cysteine metabolic circuitries: druggable targets in cancer'
organisms:
- Mus musculus
- Rattus norvegicus
- Allium cepa
- Allium sativum
- Homo sapiens
- Fusobacterium nucleatum
pmcid: PMC7921671
filename: 41416_2020_1156_Fig5_HTML.jpg
figlink: pmc/articles/PMC7921671/figure/Fig5/
number: F5
caption: a Drugs targeting cysteine metabolism. b Key inhibition targets and interplay
  between the trans-sulphuration pathway, the xCT antiporter and ferroptosis. c Inhibition
  of glutathione- and thioredoxin-dependent antioxidant pathways by sulphasalazine
  or auranofin combined with L-BSO. d Novel selenium-chrysin nanoformulations acting
  as inhibitors of glutathione bioavailability/synthesis and CBS activity. CBS cystathionine
  β-synthase, CSE cystathionine γ-lyase, GCS γ-glutamyl cysteine synthetase, GSS glutathione
  synthetase, Pyr pyruvate, α-KB α-ketobutyrate, GSH glutathione reduced form, GSSG
  glutathione oxidised form, ROS reactive oxygen species, FIN ferroptosis-inducing
  compounds.
papertitle: 'Cysteine metabolic circuitries: druggable targets in cancer.'
reftext: Vasco D. B. Bonifácio, et al. Br J Cancer. 2021 Mar 2;124(5):862-879.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9063719
figid_alias: PMC7921671__F5
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC7921671__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7921671__41416_2020_1156_Fig5_HTML.html
  '@type': Dataset
  description: a Drugs targeting cysteine metabolism. b Key inhibition targets and
    interplay between the trans-sulphuration pathway, the xCT antiporter and ferroptosis.
    c Inhibition of glutathione- and thioredoxin-dependent antioxidant pathways by
    sulphasalazine or auranofin combined with L-BSO. d Novel selenium-chrysin nanoformulations
    acting as inhibitors of glutathione bioavailability/synthesis and CBS activity.
    CBS cystathionine β-synthase, CSE cystathionine γ-lyase, GCS γ-glutamyl cysteine
    synthetase, GSS glutathione synthetase, Pyr pyruvate, α-KB α-ketobutyrate, GSH
    glutathione reduced form, GSSG glutathione oxidised form, ROS reactive oxygen
    species, FIN ferroptosis-inducing compounds.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cic
  - ci
  - oh
  - Large1
  - Cbs
  - hs
  - Cth
  - Slc7a11
  - Gss
  - fa
  - Slc25a1
  - Ccne1
  - Line
  - CIC
  - SLC25A1
  - TIMP1
  - HEMC
  - LARGE1
  - MEA1
  - CBS
  - CTH
  - VSIG2
  - SLC2A1
  - SLC7A11
  - GCLC
  - UGCG
  - GSS
  - PRNP
  - NH
  - Aminooxyacetic acid
  - AOAA
  - Benserazide hydrochloride
  - Hexachlorophene
  - Riluzole
  - Sulphasalazine
  - Fluvastatin
  - Methionine
  - Cys
  - Ser
  - Pyr
  - H
  - Piperazine
  - Cystine
  - H L-BSO
  - Fe
  - Lipid-OOH Lipid-OH
  - GSSG
  - peroxide
  - BSO
  - Auranofin
  - Sulphapyridine
  - Se
  - 5-Aminosalicylic acid
  - PURE-FA
  - Colon cancer
  - cancer
  - breast cancers
  - Fibrosarcoma
  - Liver cancer
  - lymphomas
  - lymphoma
  - glioblastoma carcinomas
---
